- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1776-260X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Durvalumab: A Review in Extensive-Stage SCLC ; volume:16 ; number:6 ; day:3 ; month:11 ; year:2021 ; pages:857-864 ; date:11.2021
Targeted oncology ; 16, Heft 6 (3.11.2021), 857-864, 11.2021
- Creator
-
Al-Salama, Zaina T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11523-021-00843-0
- URN
-
urn:nbn:de:101:1-2022020918073298452497
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Al-Salama, Zaina T.
- SpringerLink (Online service)
Other Objects (12)
Correction to: Durvalumab: A Review in Extensive-Stage SCLC
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer
First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
Curative-Intent Treatment with Durvalumab in Early-Stage Cancers
Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA
Durvalumab: A Review in Advanced Biliary Tract Cancer
Arzneimittel Profil Durvalumab
Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report
Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
Retinal Vasculitis Secondary to Durvalumab
Correction to: Durvalumab: A Review in Extensive-Stage SCLC
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer
First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
Curative-Intent Treatment with Durvalumab in Early-Stage Cancers
Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA
Durvalumab: A Review in Advanced Biliary Tract Cancer
Arzneimittel Profil Durvalumab
Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report
Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
Retinal Vasculitis Secondary to Durvalumab
Correction to: Durvalumab: A Review in Extensive-Stage SCLC
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer
First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
Curative-Intent Treatment with Durvalumab in Early-Stage Cancers
Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA
Durvalumab: A Review in Advanced Biliary Tract Cancer
Arzneimittel Profil Durvalumab
Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report
Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer